GlassScriptPhysician profile
Noel J George
NPI 1922276955
$6,532.50
in general payments reported to CMS, 2019-2025
51 companies · $39.97 in 2025
The $39.97 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,219 · 2022: $2,062 · 2023: $2,562 · 2024: $650 · 2025: $39.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,251.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $610.20 | 2022-2024 | Reblozyl, Pomalyst, Opdualag |
| Astrazeneca Pharmaceuticals LP | $567.49 | 2021-2024 | Enhertu, Imfinzi, Tagrisso |
| Novartis Pharmaceuticals Corporation | $453.03 | 2021-2024 | Kisqali, Piqray |
| E.R. Squibb & Sons, L.L.C. | $421.99 | 2021-2024 | Opdivo, Opdualag |
| Seagen INC. | $364.93 | 2021-2023 | Adcetris, Tukysa, Padcev |
| Janssen Biotech, INC. | $342.40 | 2021-2024 | Tecvayli, Talvey, Erleada |
| Genzyme Corporation | $259.19 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $257.10 | 2021-2024 | Libtayo |
| Daiichi Sankyo INC. | $249.43 | 2021-2023 | Enhertu |
| Astellas Pharma US INC | $232.85 | 2021-2025 | Xtandi, Xospata, Padcev |
| Gilead Sciences, INC. | $212.52 | 2022-2023 | Trodelvy |
| Takeda Pharmaceuticals U.S.A., INC. | $172.81 | 2022-2024 | Alunbrig, Ninlaro |
| Ipsen Biopharmaceuticals, INC | $171.98 | 2022-2024 | Somatuline Depot, Onivyde |
| Lilly USA, LLC | $165.49 | 2021-2023 | Verzenio, Jaypirca, Retevmo |
| Jazz Pharmaceuticals INC. | $161.87 | 2021-2024 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noel George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.